Bibliography
Substantial between-country differences in organising community care for older people in Europe-a review. Eur J Public Health. 26(2):213-9.
.
2016. The Prevalence and Persistence of Dizziness in Older European Home Care Recipients: A Prospective Cohort Study. Journal of the American Medical Directors Association. 21(3):338-343.e1.
.
2020. Frailty, multimorbidity patterns and mortality in institutionalized older adults in Italy. Aging Clinical and Experimental Research. 34(12):3123-3130.
.
2022. Proceedings from an International Virtual Townhall: Reflecting on the COVID-19 Pandemic: Themes from Long-Term Care. Journal of the American Medical Directors Association. 22(6):1128-1132.
.
2021. Pain therapy in German long-term care facilities in a European comparison: Results of the SHELTER study. Schmerz. 29(4):411-421.
.
2015. Body mass index and mortality among hospitalized patients. Arch Intern Med. 160(17):2641-4.
.
2000. Prevalence, country-specific prescribing patterns and determinants of benzodiazepine use in community-residing older adults in 7 European countries. BMC geriatrics. 24(1):240.
.
2024. Predictors of rehabilitation outcomes in frail patients treated in a geriatric hospital. Journal of the American Geriatrics Society. 50(4):679-84.
.
2002. Cross-Country Validation of the Association Between Oral Health and General Health in Community-Dwelling Older Adults. Journal of the American Medical Directors Association. 20(9):1137-1142.e2.
.
2019. .
2005. .
2015.
Prevalence and Risk Factors for Falls in an Older Community-Dwelling Population. The Journals of Gerontology: Series A. 57(11):M722-M726.
.
2002. Impact of COVID-19-related lockdown on psychosocial, cognitive, and functional well-being in adults with down syndrome. Frontiers in Psychiatry. 11:578686.
.
2020. The Characteristics of Diabetic Residents in European Nursing Homes: Results from the SHELTER Study. Journal of the American Medical Directors Association. 16(4):334-340.
.
2015. Antithrombotic drugs in secondary stroke prevention among a community dwelling older population. J Neurol Neurosurg Psychiatry. 74(8):1100-1104.
.
2003. Anticholinergic Medication Burden and 5-Year Risk of Hospitalization and Death in Nursing Home Elderly Residents With Coronary Artery Disease. Journal of the American Medical Directors Association. 17(11):1056-1059.
.
2016. Quality of care in European home care programs using the second generation interRAI Home Care Quality Indicators (HCQIs). BMC geriatrics. 15(148):nopagination.
.
2015. Social and functional health of home care clients with different levels of cognitive impairments. Aging & Mental Health. 21(1):18-23.
.
2017. Relationship between frailty and drug use among nursing homes residents: results from the SHELTER study. Aging Clinical and Experimental Research. 33(10):2839-2847.
.
2021. Pain Management in Frail, Community-Living Elderly Patients. Archives of Internal Medicine. 161(22):2721-2724.
.
2001. Joint Associations of Dual Sensory Impairment and No-Activity Involvement With 1-Year Mortality in Nursing Homes: Results From the SHELTER Study. Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences. 71(5):643-648.
.
2016. .
2023.
Polypharmacy in Nursing Home in Europe: Results From the SHELTER Study. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences.
.
2012. Predicting care intensity in geriatric home care patients: a comparison of different measures. Aging clinical and experimental research. 32(2):281-287.
.
2020. Benchmarking european community care delivery on costs and quality of care, a novel approach. European Geriatric Medicine. 8(Supplement 1):S30.
.
2017.